GH treatment reduces trunkal adiposity in HIV-infected patients with lipodystrophy: a randomized placebo-controlled study | Zendy

Livio Luzi | Zendy; Elena Meneghini | Zendy; Sabrina Oggionni | Zendy; Giuseppe Tambussi | Zendy; L Piceni-Sereni | Zendy; Adriano Lazzarin | Zendy

Open Access

GH treatment reduces trunkal adiposity in HIV-infected patients with lipodystrophy: a randomized placebo-controlled study

Author(s) -

Livio Luzi,

Elena Meneghini,

Sabrina Oggionni,

Giuseppe Tambussi,

L Piceni-Sereni,

Adriano Lazzarin

Publication year - 2005

Publication title -

european journal of endocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.897

H-Index - 148

eISSN - 1479-683X

pISSN - 0804-4643

DOI - 10.1530/eje.1.02039

Subject(s) - lipodystrophy , medicine , placebo , endocrinology , crossover study , trunk , basal (medicine) , human immunodeficiency virus (hiv) , insulin , viral load , immunology , antiretroviral therapy , biology , alternative medicine , pathology , ecology

HIV lipodystrophy is a common complication of highly active anti-retroviral therapy, characterized by both metabolic and morphological features. The most feared morphological feature is body fat redistribution leading to HIV lipodystrophy. GH is known to induce reduction of visceral obesity and body fat redistribution in adults.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research